The tumor mycobiome: A paradigm shift in cancer pathogenesis is a research paper published in Cell (2022). On theSindex it has a DataRank of 0. It has been cited 27 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA206105
NIA NIH HHS
Grant: R01 AG068857
NCI NIH HHS
Grant: R41 CA250892
National Institutes of Health
Grant: 1R41CA250892-01
Modulation of the gut microbiome to enhance efficacy of immunotherapy in pancreatic adenocarcinoma
National Institutes of Health
Grant: 1R01CA206105-01A1
Regulation of Pancreatic Oncogenesis by the Gut Microbiome
FWCI
1.81
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals